Hindlll polymorphism of lipoprotein lipase gene in patients with acute coronary syndrome

Hindlll polymorphism of lipoprotein lipase gene in patients with acute coronary syndrome

Aim. To study the role of lipoprotein lipase (LPL) gene HindIII polymorphism in hospital and post-hospital prognosis of acute coronary syndrome (ACS).Material and methods. The study included 423 ACS patients. In 382 participants with verified myocardial infarction (MI) and unstable angina (UA), LPL...

Full description

Bibliographic Details
Main Authors:	R. T. Saygitov, M. G. Glezer, N. A. Malygina
Format:	Article
Language:	Russian
Published:	«SILICEA-POLIGRAF» LLC 2008-12-01
Series:	Кардиоваскулярная терапия и профилактика
Subjects:	острый коронарный синдром hindiii полиморфизм ген липопротеинлипазы прогноз
Online Access:	https://cardiovascular.elpub.ru/jour/article/view/1726

Similar Items

ACE gene ID polymorphism in acute coronary syndrome patients
by: R. T. Saygitov, et al.
Published: (1970-01-01)

Gender-specific prognosis in acute coronary syndrome
by: R. T. Saygitov, et al.
Published: (2006-02-01)

Acute coronary syndrome in clinical practice: gender specifics of risk levels, treatment, and outcomes: RECORD Registry results
by: A. D. Erlikh, et al.
Published: (1970-01-01)

Prediction of the long-term risk of adverse cardiovascular events after an episode of acute coronary syndrome in patients with type 2 diabetes
by: E. A. Nikitina, et al.
Published: (2020-07-01)

Adding cystatin C to the GRACE scale improves the prediction of bleeding complications in non-invasively treated patients with acute coronary syndrome
by: M. S. Kharchenko, et al.
Published: (2012-12-01)

Russian National Registry of acute coronary syndrome: present state and perspectives
by: S. A. Boytsov, et al.
Published: (2007-08-01)

Prospective study one-year clinical outcomes of the Calypso coronary stent in patients presenting with acute coronary syndrome
by: В. Л. Воробьев, et al.
Published: (2017-04-01)

Reactive oxygen species production by blood leukocytes and its correction by trimetazidine MB in patients with acute coronary syndrome
by: M. G. Glezer, et al.
Published: (2009-08-01)

ANTICOAGULANTS IN ACUTE CORONARY SYNDROME
by: I. A. Latfullin, et al.
Published: (2016-01-01)

Statins in acute coronary syndrome
by: O. M. Drapkina
Published: (2009-10-01)

SECONDARY MITOCHONDRIAL DYSFUNCTION IN ACUTE CORONARY SYNDROME
by: Y. A. Vasyuk, et al.
Published: (2015-12-01)

Coronary Arterial Stenting in Acute Coronary Syndrome
by: S. O. Sokolova, et al.
Published: (2006-02-01)

THE STRUCTURE OF DRUG PRESCRIPTION IN ACUTE CORONARY SYNDROME WITHOUT ST SEGMENT ELEVATION ON THE FIRST DAY OF HOSPITAL THERAPY
by: O. V. Reshetko, et al.
Published: (2016-01-01)

IMMEDIATE RESULTS OF DELAYED PERCUTANEOUS CORONARY INTERVENTIONS IN PATIENTS WITH ACUTE CORONARY SYNDROME
by: S. D. Chevgun, et al.
Published: (2017-12-01)

Prognostic value of the cardiac fraction of fatty acid binding protein in patients with non-ST elevation acute coronary syndrome with concomitant type 2 diabetes
by: S. A. Berns, et al.
Published: (2019-06-01)

ANALYSIS OF PRE-HOSPITAL TREATMENT OF ACUTE CORONARY SYNDROME
by: O. V. Reshetko, et al.
Published: (2015-12-01)

ABOUT SOME MISTAKES AND REASONS FOR THEM IN ACUTE CORONARY SYNDROME TREATMENT
by: G. I. Zimarin, et al.
Published: (2015-12-01)

TETANIC CRISIS IN EMERGENCY CARDIOLOGY — DIFFICULTIES DIFFERENTIAL DIAGNOSIS OF ACUTE CORONARY SYNDROME
by: V. V. Rezvan, et al.
Published: (2016-10-01)

IMMUNOMARKERS IN ACUTE CORONARY SYNDROME UPON ADMISSION AND ITS TRANSITION TO MYOCARDIAL INFARCTION
by: Marzhanat G. Alieva
Published: (2017-12-01)

TO THE QUESTION OF EFFICACY AND SAFETY OF FORTELYZIN® THERAPY ON ACUTE CORONARY SYNDROME: TWO CLINICAL CASES
by: D. S. Yunevich, et al.
Published: (2018-03-01)

PECULIARITIES OF PARAMETERS OF ECHOCARDIOGRAPHY IN PATIENTS WITH ACUTE CORONARY SYNDROMES WITH COMORBID ANXIETY AND DEPRESSIVE DISORDERS
by: N. Yu. Shimohina, et al.
Published: (2014-12-01)

Aggressive statin therapy in acute coronary syndrome: therapeutic potential of atorvastatin in the daily dose of 80 mg
by: A. N. Britov
Published: (2009-12-01)

ALTERNATIVE APPROACHES TO THE USE OF TWO COMPONENT ANTIPLATELET THERAPY IN PATIENTS WITH ACUTE CORONARY SYNDROME: EVIDENCES, RECOMMENDATIONS AND REAL PRACTICE
by: S. R. Gilyarevskiy, et al.
Published: (2015-12-01)

Prevalence and clinical and prognostic value of “intact” coronary arteries in patients with acute coronary syndrome
by: O. L. Barbarash, et al.
Published: (2011-02-01)

RISK STRATIFICATION, REGISTERS AND PROGNOSTIC SCALES IN ACUTE CORONARY SYNDROME
by: Marzhanat G. Alieva
Published: (2017-10-01)

FEATURES OF CURRENT ACUTE CORONARY OF A SYNDROME/ACUTE MYOCARDIAL INFARCTION AT THE WOMEN IN ONE OF AREAS OF CITY OF TASHKENT (fragment of the register ACS/AMI)
by: D. E. Abidova, et al.
Published: (2017-03-01)

Pharmacodynamics and clinical effectiveness of clopidogrel and atorvastin in patients with acute coronary syndrome and hyperlipidaemia
by: A. S. Sivkov, et al.
Published: (2009-08-01)

Bleeding risk scales in patients with acute coronary syndrome: place of the ORACUL scale
by: V. A. Brazhnik, et al.
Published: (2020-11-01)

Single-center register of myocardial revascularization in patients with coronary artery disease and acute coronary syndrome in the context of COVID-19 pandemic
by: O. V. Kamenskaya, et al.
Published: (2021-10-01)

Pregnancy-associated plasma protein – a new biochemical marker of acute coronary syndrome and poor prognosis predictor in coronary heart disease patients
by: O. P. Shevchenko, et al.
Published: (2006-08-01)

LONG-TERM ANTICOAGULATION THERAPY IN SECONDARY PREVENTION OF ACUTE CORONARY SYNDROME: HOW TO CHOOSE THE PATIENT?
by: A. L. Komarov
Published: (2016-07-01)

EXPERIENCE LONG-TERM USE OF INTRA-AORTIC BALLOON COUNTER PULSATION IN PATIENTS WITH ACUTE CORONARY SYNDROME
by: V. V. Rezvan, et al.
Published: (2016-08-01)

New perspectives in immunological diagnostics of coronary heart disease
by: S. I. Davydov, et al.
Published: (2012-02-01)

Regarding the choice of Р2У<sub>12</sub> platelet receptor blocker in the early invasive approach to acute coronary syndrome treatment in patients without indications for long-term anticoagulant use
by: I. S. Yavelov
Published: (2020-12-01)

LEFT VENTRICLE FUNCTIONAL STATUS DYNAMICS THROUGH VARIOUS ISCHEMIA CLINICAL COURSES AFTER AN ENDURED ACUTE CORONARY SYNDROME
by: D. A. Shvets, et al.
Published: (2017-12-01)

Acute coronary syndrome: pre-hospital lethality structure
by: Ya. L. Gabinsky, et al.
Published: (2007-12-01)

SUMMARY OF CONCLUSIONS FROM A CONSENSUS PANEL OF EXPERTS ON THE IMPORTANCE OF RIVAROXABAN IN THE MANAGEMENT OF PATIENTS RECOVERING FROM ACUTE CORONARY SYNDROME
by: M. Ya. Ruda, et al.
Published: (2015-12-01)

Echo-cardiographic parameters for atrial fibrillation in combination with acute coronary syndrome in real clinical practice according to register of acute coronary syndrome in the Krasnodar region
by: Z. G. Tatarintseva, et al.
Published: (2019-04-01)

Diagnostic and prognostic role of PAPP-A and inflammatory markers in various forms of coronary heart disease
by: A. O. Shevchenko, et al.
Published: (2010-06-01)

Results bivalirudin use in actual practice in patients with acute coronary syndrome during percutaneous coronary intervention
by: Z H Shugushev, et al.
Published: (2014-12-01)